1. Home
  2. Browse
  3. Pediatrics
  4. Resources
  5. Guidelines

Guidelines

31 - 45 of 48 Results
Sort Results:
Guideline: Febrile Seizures: Clinical Practice Guideline for the Long-term Management of the Child With Simple Febrile Seizures (2008) September 2008
Guideline: Management of Dyslipidemia in Children and Adolescents with Diabetes (2003) August 2008
Guideline: Lipid Screening and Cardiovascular Health in Childhood (2008) August 2008
Guideline: Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children August 2008
Guideline: Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents (2007) August 2008
Guideline: American Heart Association Scientific Statement: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving ADHD Medications: Correction June 2008
Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: American Heart Association Scientific Statement: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving ADHD Medications. June 2008
Commentary: Metabolic Syndrome in Children and Adolescents June 2008
Guideline: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. June 2008
Guideline: Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity June 2008
Guideline: Type 2 Diabetes in Children and Adolescents June 2008
Guideline: Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents June 2008
Commentary: “Off-Label” Uses of Ondansetron January 2008